GlycoMimetics Reports Highlights and Financial Results for First Quarter 2021

Go back to GlycoMimetics Reports Highlights and Financial Results for First Quarter 2021

GlycoMimetics (GLYC) Tops Q1 EPS by 4c

May 3, 2021 7:34 AM EDT

GlycoMimetics (NASDAQ: GLYC) reported Q1 EPS of ($0.28), $0.04 better than the analyst estimate of ($0.32).

Our recent achievements, both in our collaboration with Apollomics and in data presentations at AACR, underscore the productivity of our pipeline. Working closely with investigators, regulators and collaborators, we are... More